期刊文献+

CRP和VEGF在川崎病患儿血清中的表达和临床意义 被引量:8

Expressions and clinical significances of CRP and VEGF in serum of children with Kawasaki disease
原文传递
导出
摘要 目的:动态研究川崎病(KD)患儿血清中C-反应蛋白(C-reactive protein,CRP)和血管内皮生长因子(vascular endothelial growth factor,VEGF)在小儿川崎病血管损伤中的作用机制,寻找其与冠状动脉(简称冠脉)损伤之间直接关系的依据。方法:应用酶联免疫吸附实验(ELISA)和免疫乳胶比浊法检测47例川崎病患儿、19例发热疾病患儿(对照组)血清中的CRP和VEGF水平,并将KD患儿分为急性期、亚急性期、恢复期;有冠脉损伤(CAL)组和无冠脉损伤(NCAL)组。结果:KD患儿急性期、亚急性期和恢复期的CRP、VEGF水平均高于发热组,两组间差异有统计学意义(P<0.01);CAL组CRP、VEGF水平明显高于NCAL,差异有统计学意义(P<0.01)。CRP的高峰期在急性期,VEGF的高峰期在亚急性期。结论:CRP和VEGF水平在KD患儿组急性期和亚急性期升高,可能在川崎病患儿血管损伤的病理生理发生机制中发挥重要作用。CRP和VEGF具有预示KD患儿CAL潜在的可能性。 Objective: To dynamically research the mechanism of serum C - reactive protein and vascular endothelial growth factor in children with Kawasaki disease, and find the relationship between C - reactive protein, vascular endothelial growth factor and coronary ar- tery lesion. Methods: The serum levels of C - reactive protein and vascular endothelial growth factor in 47 patients with Kawasaki disease and 19 patients with febrile disease (control group) were detected by double antibody sandwich enzyme linked immunosorbent assay (ELISA) and immunonephelometry, respectively. The patients with Kawasaki disease were divided into acute phase group, subacute phase group, and recovery phase group, as wells as coronary artery lesion group and non - coronary artery lesion group. Results : The serum tewds of C - reactive protein and vascular endothelial growth factor in children with Kawasaki disease in acute phase group, subacute phase group, and recovery phase group were statistically significantly higher than those in control group (P 〈 0. 01 ) . The serum levels of C - reactive pro- tein and vascular endothelial growth factor in coronary artery lesion group were statistically significantly higher than those in non - coronary artery lesion group ( P 〈 0.01 ) . The peak level of C - reactive protein appeared in the acute phase. The peak level of vascular endothelial growth factor appeared in the subacute phase. Conclusion : The increases of plasma C - reactive protein and vascular endothelial growth fac- tor levels in acute phase and subacute phase of Kawasaki disease might play important roles in pathophysiology of endothelial damage. Those may potentially be predictors of coronary artery lesion in patients with Kawasaki disease.
作者 刘颖
出处 《中国妇幼保健》 CAS 北大核心 2013年第9期1432-1434,共3页 Maternal and Child Health Care of China
关键词 川崎病 C-反应蛋白 血管内皮生长因子 儿童 Kawasaki disease C - reactive protein Vascular endothelial growth factor Child
  • 相关文献

参考文献10

  • 1Kim DS, Han BH, Lee SK et al. Evidence fox selection of 11 amino acid CDR3 domains in V kappa III derived immunoglob- ulin light in Kawasaki disease [ J ]. Scand J RhenmatoJ, 1997, 26:350.
  • 2Satou GM, Giamelli J, Cewitz MH. Kawasaki disease: diag- nosis, management, and long-term implications [J] . Car- diol Rev, 2007, 15 (4): 163.
  • 3覃秀川,张宇辉.C反应蛋白与冠心病[J].国外医学(老年医学分册),1999,20(3):105-108. 被引量:19
  • 4刘杰,孙晗笑.单核细胞趋化蛋白-1生物学特性及应用研究[J].生命的化学,2001,21(6):464-467. 被引量:15
  • 5Zwara TP, Hombaeh V, Torzewsri J. C -reactive protein me- diated low density lipoprotein up tare by macrophages : implica- tions for atherosclerosis [ J] . Circulation , 2001, 103 (7) : 1194.
  • 6黄新苗,秦永文.血管内皮生长因子用于治疗性血管生成的问题及对策[J].心血管病学进展,2005,26(4):413-417. 被引量:1
  • 7Ware JA. Too many vessels. Not enough. The wrong kind. The VEGF debate continues [J] . Nat Med, 2001, 7 (4) : 403.
  • 8Arras M, Ito WO, Scholz D et al. Monocyte activation in an- giogenesis and collateral growth in the rabbit hind limb [ J ] . J Clin Invest, 1998, 101 : 40.
  • 9Hamamichi Y, Ichida F, Yu X et al. Neutrophils and mononu- clear ceils express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions [J] . Pediatr Res, 2001, 49 (1) : 74.
  • 10Ohno T, Yuge T, Kariyazono H et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease [ J] Eur J Pediatr, 2002, 161 (2): 105.

二级参考文献44

  • 1Tang K F,Hum Pathology,2001年,32卷,1期,42页
  • 2Dor Y,Djonov V,Abramovitch R,et al.Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy[J].EMBO J,2002,21(8):1939-1947.
  • 3Menasche P.Myoblast-based cell transplantation[J].Heart Fail Rev,2003,8(3):221-227.
  • 4Suzuki K,Murtuza B,Smolenski RT,et al.Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts[J].Circulation,2001,104(12 Suppl 1):I207-I212.
  • 5Germani A,Di Carlo A,Mangoni A,et al.Vascular endothelial growth factor modulates skeletal myoblast function[J].Am J Pathol,2003,163(4):1417- 1428.
  • 6Baumgartner I,Rauh G,Pieczek A,et al.Lower-extremity edema associatedwith gene transfer of naked DNA encoding vascular endothelial growth factor [J].Ann Intern Med,2000,132:880-884.
  • 7Hedman M,Hartikainen J,Syvanne M,et al.Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia:phase Ⅱ results of the Kuopio Angiogenesis Trial (KAT)[J].Circulation,2003,107(21):2677-2683.
  • 8Henry TD,Rocha-Singh K,Isner JM,et al.Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial[J].Am Heart J,2001,142:878-880.
  • 9Henry TD,Abraham JA.Review of preclinical and clinical results with vascular endothelial growth factor for therapeutic angiogenesis[J].Curr Int Card Rep,2000,2:228-241.
  • 10Jain RK,Munn LL.Leaky vessels? Call Ang1[J]! Nat Med,2000,6:131-132.

共引文献32

同被引文献52

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部